A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

NCT07393659 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Fostemsavir
DRUG: Dolutegravir (DTG)/ Lamivudine (3TC)

Sponsor

ViiV Healthcare